Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

Jeremie Vitte · SciRah

Researcher profile · Semantic Scholar

Jeremie Vitte

University of California, Los Angeles

Share profile

Jeremie Vitte — researcher profile on SciRah

ORCID iD 0000-0002-2567-7988Homepage

h-index: 14
Works: 37
Citations: 1,105

Most-cited papers

A mutation of spastin is responsible for swellings and impairment of transport in a region of axon characterized by changes in microtubule composition.
A. Tarrade, C. Fassier, Sabrina Courageot, D. Charvin +10 more
2006Human Molecular Genetics197 citations Open access
Semantic Scholar
Update From the 2011 International Schwannomatosis Workshop: From Genetics to Diagnostic Criteria
S. Plotkin, J. Blakeley, D. Evans, C. Hanemann +12 more
2013American Journal of Medical Genetics. Part A174 citations Open access
Semantic Scholar
Refined characterization of the expression and stability of the SMN gene products.
Jeremie Vitte, C. Fassier, F. Tiziano, Cécile Dalard +6 more
2007American Journal of Pathology118 citations Open access
Semantic Scholar
Deletion of murine Smn exon 7 directed to liver leads to severe defect of liver development associated with iron overload.
Jeremie Vitte, Bénédicte Davoult, Natacha Roblot, M. Mayer +7 more
2004American Journal of Pathology114 citations Open access
Semantic Scholar
Expanding the mutational spectrum of LZTR1 in schwannomatosis
I. Paganini, Vivian Y. Chang, G. L. Capone, Jeremie Vitte +8 more
2014European Journal of Human Genetics78 citations Open access
Semantic Scholar
mTORC1 inhibition delays growth of neurofibromatosis type 2 schwannoma.
M. Giovannini, N. Bonne, Jeremie Vitte, F. Chareyre +7 more
2014Neuro-Oncology75 citations Open access
Semantic Scholar
Leucine-Rich Repeat Kinase 2 Is Associated With the Endoplasmic Reticulum in Dopaminergic Neurons and Accumulates in the Core of Lewy Bodies in Parkinson Disease
Jeremie Vitte, Sabine Traver, A. Maués De Paula, S. Lesage +4 more
2010Journal of Neuropathology and Experimental Neurology72 citations Open access
Semantic Scholar
Genetically engineered minipigs model the major clinical features of human neurofibromatosis type 1
Sara H. Isakson, A. Rizzardi, Alex Coutts, D. F. Carlson +18 more
2018Communications Biology67 citations Open access
Semantic Scholar
Parkin Deficiency Delays Motor Decline and Disease Manifestation in a Mouse Model of Synucleinopathy
M. Fournier, Jeremie Vitte, Jérôme Garrigue, D. Langui +19 more
2009PLoS ONE40 citations Open access
Semantic Scholar
Therapeutic Potential of HSP90 Inhibition for Neurofibromatosis Type 2
Karo Tanaka, Ascia Eskin, F. Chareyre, W. Jessen +9 more
2013Clinical Cancer Research38 citations Open access
Semantic Scholar
Preclinical assessment of MEK1/2 inhibitors for neurofibromatosis type 2–associated schwannomas reveals differences in efficacy and drug resistance development
Marisa A. Fuse, Christine T. Dinh, Jeremie Vitte, Joanna M. Kirkpatrick +21 more
2019Neuro-Oncology37 citations Open access
Semantic Scholar
Rac1-mediated DNA damage and inflammation promote Nf2 tumorigenesis but also limit cell cycle progression
Yuhao Shi, Saumya R. Bollam, Shannon M. White, Sean Z. Laughlin +8 more
2016Developmental Cell32 citations Open access
Semantic Scholar
An allograft mouse model for the study of hearing loss secondary to vestibular schwannoma growth
N. Bonne, Jeremie Vitte, F. Chareyre, G. Karapetyan +4 more
2016Journal of Neuro-Oncology18 citations
Semantic Scholar
Double somatic SMARCB1 and NF2 mutations in sporadic spinal schwannoma
I. Paganini, G. L. Capone, Jeremie Vitte, R. Sestini +3 more
2018Journal of Neuro-Oncology14 citations
Semantic Scholar
Gene-targeted therapy for neurofibromatosis and schwannomatosis: The path to clinical trials
Verena Staedtke, K. Anstett, D. Bedwell, Marco Giovannini +11 more
2023Clinical Trials11 citations Open access
Semantic Scholar
Imaging as an early biomarker to predict sensitivity to everolimus for progressive NF2-related vestibular schwannoma
P. Nghiemphu, Jeremie Vitte, E. Dombi, Thien Nguyen +9 more
2024Journal of Neuro-Oncology7 citations Open access
Semantic Scholar
Linked-read Sequencing Analysis Reveals Tumor-specific Genome Variation Landscapes in Neurofibromatosis Type 2 (NF2) Patients.
Daniel S Roberts, Rahul Maurya, Yuka Takemon, Jeremie Vitte +11 more
2019Otology and Neurotology5 citations
Semantic Scholar
Cold Atmospheric Plasma Induces Growth Arrest and Apoptosis in Neurofibromatosis Type 1-Associated Peripheral Nerve Sheath Tumor Cells
Brian Na, Blake Haist, Shilp R. Shah, Graeme Sabiston +4 more
2024Biomedicines3 citations Open access
Semantic Scholar
Immunotherapeutic Targeting of NY-ESO-1 in Malignant Meningiomas with TCR-Transduced T-Cells
Matthew Z Sun, Erick M. Contreras, J. Treger, M. Imbroane +11 more
2025Journal of Neuro-Oncology2 citations
Semantic Scholar
Potential of HSP90 Inhibitors to Treat Neurofibromatosis-Related Tumors
Jeremie Vitte, M. Giovannini
20152 citations
Semantic Scholar
Conditional Inactivation of SMARCB1 in P0 Permissive Mouse Cells Generates Rhabdoid Tumors in the Peripheral Nervous System
Jeremie Vitte, F. Chareyre, A. Stemmer-Rachamimov, A. Judkins +1 more
20142 citations
Semantic Scholar
EXTH-87. DECITABINE POTENTIATES MENINGIOMA IMMUNOTHERAPY TARGETING NY-ESO-1
Matthew Z Sun, J. Orpilla, Erick M. Contreras, M. Imbroane +8 more
2022Neuro-Oncology1 citations Open access
Semantic Scholar
Quantitative imaging of schwannoma captures heterogeneity and accelerates preclinical testing, revealing distinct impacts of targeted therapies
E. A. Wright, Jeremie Vitte, Sara I. Veiga, Sarah E. Bushnell +8 more
2026bioRxiv0 citations Open access
Semantic Scholar
Merlin restoration prevents schwannoma progression in a genetically engineered mouse model of NF2 -SWN
Jeremie Vitte, C. Chiasson-MacKenzie, Banumathi K. Cole, A. McClatchey +1 more
2026bioRxiv0 citations Open access
Semantic Scholar
Development of a Genetically Engineered Porcine Model of Rhabdoid Tumor Predisposition Syndrome Type 1 (RTPS-1)
Brian Na, C. D. Rubinstein, J. Meudt, Fausto J. Rodriguez +5 more
2026Cancers0 citations Open access
Semantic Scholar
DNAR-14. EZH2 inhibition as a potential therapeutic avenue in the treatment of meningioma
Joshua Casaos, Jeremie Vitte, Travis Perryman, Maya Harary +2 more
2025Neuro-Oncology0 citations
Semantic Scholar
Combination Therapy with Mtor Inhibition and Ionizing Radiation in Meningioma Results In Superior Cytostatic Effect than Monotherapy
Maya Harary, Elizabeth Fernandez, Joshua Casaos, Jeremie Vitte +5 more
202433rd Annual Meeting North American Skull Base Society0 citations
Semantic Scholar
Basal BCL-2-Interacting Mediator of Cell Death (BIM) Responsiveness Correlates with Radiosensitivity in Meningioma
Maya Harary, Elizabeth Fernandez, Joshua Casaos, Jeremie Vitte +5 more
202433rd Annual Meeting North American Skull Base Society0 citations
Semantic Scholar
DDDR-48. EZH2 INHIBITION AS A POTENTIAL THERAPEUTIC AVENUE IN THE TREATMENT OF MENINGIOMA
Joshua Casaos, Jeremie Vitte, Travis Perryman, Maya Harary +4 more
2024Neuro-Oncology0 citations Open access
Semantic Scholar
DDDR-49. REPURPOSING OF THE ANTI-VIRAL DRUG RIBAVIRIN AS A POTENTIAL MENINGIOMA THERAPEUTIC
Joshua Casaos, Travis Perryman, Maya Harary, Jeremie Vitte +4 more
2024Neuro-Oncology0 citations Open access
Semantic Scholar
Functional Classification of Apoptotic Sensitivity in Meningioma
Maya Harary, E. Fernández, Joshua Casaos, Jeremie Vitte +4 more
202332nd Annual Meeting North American Skull Base Society0 citations
Semantic Scholar
RBIO-11. BASAL BCL-2-INTERACTING MEDIATOR OF CELL DEATH (BIM) RESPONSIVENESS CORRELATES WITH RADIOSENSITIVITY IN MENINGIOMA
Maya Harary, Elizabeth Fernandez, Joshua Casaos, Jeremie Vitte +5 more
2023Neuro-Oncology0 citations Open access
Semantic Scholar
MODL-13. GENETICALLY ENGINEERED PIG MODEL OF RHABDOID TUMOR PREDISPOSITION SYNDROME-1
Brian Na, C. Rubinstein, J. Meudt, J. Biegel +6 more
2020Neuro-Oncology0 citations Open access
Semantic Scholar
TMOD-15. SPATIOTEMPORAL LOSS OF SMARCB1 IN EARLY NEURAL CREST LINEAGE LEADS TO DIFFERENT MOLECULAR SUBTYPES OF RHABDOID TUMORS
Jeremie Vitte, Fuying Gao, G. Coppola, A. Judkins +1 more
2019Neuro-Oncology0 citations Open access
Semantic Scholar
TMOD-23. PRECLINICAL DRUG EVALUATION IN A GENETICALLY ENGINEERED MINIPIG MODEL OF NEUROFIBROMATOSIS TYPE 1
Sara H. Osum, A. Stemmer-Rachamimov, B. Widemann, E. Dombi +10 more
2019Neuro-Oncology0 citations Open access
Semantic Scholar
PM-02CONDITIONAL INACTIVATION OF SMARCB1 IN P0 PERMISSIVE MOUSE CELLS GENERATES RHABDOID TUMORS IN THE PERIPHERAL NERVOUS SYSTEM AND IN THE BRAIN
Jeremie Vitte, F. Chareyre, A. Stemmer-Rachamimov, A. Judkins +1 more
20150 citations Open access
Semantic Scholar
Spinal muscular atrophy.
Jeremie Vitte, Ruben Attali, N. Warwar, Irena Gurt +1 more
2009Advances in Experimental Medicine and Biology0 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. Giovannini×18
Invite
M. Giovannini — researcher profile on SciRah
Marco Giovannini×13
Invite
Marco Giovannini — researcher profile on SciRah
Richard G. Everson×7
Invite
Richard G. Everson — researcher profile on SciRah
Maya Harary×7
Invite
Maya Harary — researcher profile on SciRah

Invite

Brian Na — researcher profile on SciRah

Joshua Casaos×6

Invite

Joshua Casaos — researcher profile on SciRah

A. Stemmer-Rachamimov×5

Invite

A. Stemmer-Rachamimov — researcher profile on SciRah

Invite

F. Chareyre — researcher profile on SciRah

Invite

A. Judkins — researcher profile on SciRah

Natacha Roblot×3

Invite

Natacha Roblot — researcher profile on SciRah

Invite

J. Melki — researcher profile on SciRah

Invite

L. Messiaen — researcher profile on SciRah